Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. CI&T Inc.
  6. News
  7. Summary
    CINT   KYG213071064

CI&T INC.

(CINT)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 01/18 04:00:04 pm
13.25 USD   +9.78%
01/14Tech Stocks Rebound This Afternoon, Led Higher by Chipmakers
MT
01/14CI&T to Buy UK Digital Product Agency Somo Global
MT
01/14CI&T Acquires Somo to Accelerate Its Growth in EMEA
BU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CI&T Reports Third Quarter Financial Results

12/01/2021 | 05:59pm EST

CI&T (“Company”, NYSE: CINT), a global digital specialist, today announces its results for the third quarter of 2021 (3Q21) and for the nine months ended September 30, 2021 (9M21). For comparison reasons, we refer to the results for the third quarter of 2020 (3Q20) and for the nine months ended September 30, 2020 (9M20).

Our financial results from 3Q21 and 9M21 contemplate the consolidation of Dextra as of August 10, 2021, while our pro forma results consider the acquisition of Dextra as if the acquisition had occurred on January 1, 2021.

3Q21 Highlights:

  • Net revenue of R$376.0 million, a 55% growth year-over-year (57% in constant currency basis).
  • 44% net revenue growth in the U.S. market compared with 3Q20.
  • Pro forma net revenue of R$411.1 million.

Cesar Gon, CEO of CI&T, commented "This is our first earnings release since we became a publicly traded company a few weeks ago and I would like to thank all investors for your trust and support throughout this process. In a total offering of US$225 million, CI&T raised US$157 million in net proceeds, which we intend to use to fund our continuous growth.

We are very excited to present a robust 55% year-over-year net revenue growth in the quarter with consistent profitability, even compared to a solid 3Q20 results. This growth was boosted by higher demand from existing clients combined with the addition of new clients to our portfolio, representing our 21st consecutive quarter of net revenue growth. We continue to observe a strong demand environment and we expect our net revenue in the fourth quarter of 2021 to be at least R$440.0 million, a 66% growth year-over-year."

On August 10, 2021, we concluded the acquisition of Dextra, a company based in Brazil focused on customized software development and an expert in combining design methodologies, agile development and data science to deliver digital products to its clients. With a solid client portfolio, Dextra will allow us to further diversify our client base, as well as strengthen our ability to deliver high quality services to our clients.

The number of clients with net revenue above R$1 million in the last twelve months (LTM) grew from 62 in 2Q21 to 75 in the quarter in all regions (Latam, North America, Europe and APAC), which we expect will contribute to foster our revenue growth in the following years. In terms of geographies, all regions are on a growth trajectory, with the USA continuing to be a fast growing market, with a 44% growth in the period.

We onboarded 1,364 net new employees during 3Q21, including 1,167 from Dextra, totaling 5,398 CI&Ters by the end of the quarter. We continue to develop our people training actions (CI&T University), fostering career opportunities and growth at all levels.

During the quarter, we began a new R&D joint project, named Cognitive Lab (C-Lab), along with UNICAMP, one of the most respected Brazilian universities, and a few CI&T clients, to develop machine learning tools on human dialogues, aimed at automating customer service processes.

Pro forma financial highlights, including the Dextra acquisition as if the acquisition had occurred on January 1st, 2021

For 3Q21(1):

  • Pro forma net revenue of R$411.1 million.
  • Pro forma adjusted EBITDA of R$91.8 million and 22.3% adjusted EBITDA margin.
  • Pro forma net profit of R$1.7 million.
  • Pro forma adjusted net profit of R$27.4 million and 6.7% adjusted net profit margin.

For 9M21:

  • Pro forma net revenue of R$1,160.5 million.
  • Pro forma adjusted EBITDA of R$277.5 million and 23.9% adjusted EBITDA margin.
  • Pro forma net profit of R$88.8 million and 7.6% net profit margin.
  • Pro forma adjusted net profit of R$117.2 million and 10.1% adjusted net profit margin.

(1) The Pro Forma numbers for the three months ended September 30, 2021 (3Q21) are derived from the difference of the unaudited pro forma condensed statement of profit and loss for the nine months ended September 30, 2021 and the unaudited pro forma condensed statement of profit or loss for the six months ended June 30, 2021.

3Q21 CI&T Financial highlights, including the Dextra acquisition as of August 10, 2021

  • Net revenue of R$376.0 million, an increase of R$133.1 million compared to 3Q20, a 55% growth in the period, of which 36% was organic growth and 19% was related to the Dextra acquisition as of August 10th.
  • Net revenue growth on a constant currency basis was 57% year-over-year.
  • 3Q21 net revenue breakdown:
    • by industry vertical: financial services 36%; food & beverages 21%; pharmaceuticals and cosmetics 14%; technology, media and telecom 12%; and others 17%.
    • by geographic region: USA 44%; Brazil 51%; Asia Pacific and Japan 3%; and Europe 2%.
    • by client concentration: top one client 17%; and top 10 clients 60%.
  • Adjusted EBITDA of R$80.1 million, an increase of R$14.8 million or 23% over 3Q20. Adjusted EBITDA margin was 21.3%.
  • Net loss of R$2.2 million, compared to a net profit of R$39.5 million in the same quarter of 2020.
  • Adjusted net profit of R$24.5 million in the quarter, a reduction of R$15.3 million in relation to 3Q20. Adjusted net profit margin was 6.5%.

Comments on the 3Q21 financial performance

Net revenue was R$376.0 million, an increase of R$133.1 million or 55% year-over-year, mainly due to higher demand for digital transformation from our existing clients and the addition of new clients to our portfolio, combined with the consolidation of Dextra as of August 10, 2021. In terms of geographic region, the highlight for the quarter was the net revenue increase in the U.S., from R$114.6 million in 3Q20 to R$165.0 million in 3Q21, a 44% growth.

The costs of services provided amounted to R$246.8 million in the quarter, an increase of R$96.5 million or 64% in relation to 3Q20, mainly due to higher costs with employees, related to employee promotions and new hires in response to the growing demand for our services.

As a result, gross profit was R$129.1 million in the quarter, R$36.5 million higher than 3Q20. Adjusted gross profit totaled R$139.6 million in 3Q21, an increase of 41% over the same quarter last year, with an adjusted gross margin of 37.1% in the quarter, compared to 40.6% in 3Q20. The gross profit was adjusted for costs related to depreciation and amortization and stock options compensation plan expenses. See "Reconciliation of Non-IFRS measures" for reconciliation of adjusted gross profit to gross profit.

Selling, general and administrative (SG&A) expenses in 3Q21 totaled R$63.1 million, an increase of R$28.0 million or 80% over the same period last year, mainly related to (i) an increase in employee expenses related to new hires to strengthen the finance, accounting, legal and compliance departments in preparation for becoming a publicly-listed company, (ii) an increase of R$ 4.3 million in provisions for profit sharing related to the Dextra acquisition and (iii) M&A expenses associated with legal and accounting due diligence.

Other operating expenses of R$25.3 million in the quarter were related to the impairment of intangible assets of R$21.8 million recognized in 3Q21, a non-cash and one-off effect, as CI&T decided to discontinue investments made by Dextra on certain in progress intangible assets related to digital platforms, and R$3.1 million attributable to the issuance of new shares in connection with the IPO.

Adjusted EBITDA totaled R$80.1 million, 23% higher than 3Q20, with an adjusted EBITDA margin of 21.3% compared to 26.9% in 3Q20. The adjusted EBITDA in the quarter reflects higher costs of services provided and SG&A expenses, as explained above, while 3Q20 recorded an outstanding result, benefited by the favorable foreign exchange rate. See "Reconciliation of Non-IFRS measures" for reconciliation of adjusted EBITDA to net profit.

Net financial expenses were R$22.4 million in 3Q21, compared to R$1.9 million in 3Q20, as the Company incurred R$650 million in new debt during the quarter to finance the Dextra acquisition, which will mature in 2026. Income tax expenses, including current and deferred tax, was R$18.9 million, a R$2.5 million increase or 15% compared to 3Q20.

Therefore, the net loss of R$2.2 million in the quarter was mainly due to the impairment of intangible assets of R$21.8 million, a non-cash effect. Adjusted net profit was R$24.5 million in the quarter, a reduction of R$15.3 million in relation to 3Q20, mainly due to higher financial expenses and an increase in depreciation and amortization, both associated with the Dextra acquisition. Net profit was adjusted for the impairment of intangible assets and consulting expenses associated with the corporate reorganization and the IPO, as well as M&A activities.

Cash Flow and Other Metrics

  • Cash generated from operating activities was R$90.2 million in the 9M21, compared to R$102.7 million in the 9M20.
  • Cash and cash equivalents totaled R$113.4 million at the end of 3Q21, while total debt (loans and borrowings) ended the quarter at R$782.1 million.
  • Net debt (defined as total debt (loans and borrowings) minus cash and cash equivalents) at the end of the quarter was R$668.7 million.
  • Considering the net proceeds from the IPO of US$156.7 million, net of underwriting discounts and commissions, the Company has a cash position higher than its outstanding debt as of November, 2021.
  • Total headcount at the end of 3Q21 was 5,398 CI&Ters, an addition of 1,364 people, including 1,167 from Dextra, when compared to 2Q21.

Business Outlook

We continue to see strong demand for digital transformation services worldwide. We expect our revenue growth to continue accelerating during 4Q21, based on our engagement with current clients and existing master services agreements, combined with our pipeline of potential new clients, as well as the contribution of net revenue from the consolidation of Dextra.

Therefore, we expect our net revenue in the fourth quarter of 2021 to be at least R$440.0 million, a 66% growth compared to our net revenue of R$ 265.4 million in the fourth quarter of 2020.

For the full year of 2021, we expect our pro forma net revenue to be at least R$1,600 million, a 38% growth compared to our pro forma net revenue of R$1,161 million in 2020.

These expectations are forward-looking statements. See "Cautionary Statement on Forward-Looking Statements" below.

Initial Public Offering (IPO)

On November 15, 2021 we concluded our IPO, consisting of 15 million class A common shares, of which 11.1 million shares were offered by CI&T and 3.9 million shares were offered by certain selling shareholders. The Company did not receive any proceeds from the sale of our common stock by the selling stockholders. We received net proceeds of US$156.7 million upon the closing of the IPO, after deducting the underwriting discounts and commissions. The shares began trading on the New York Stock Exchange (NYSE) on November 10, 2021, under the ticker symbol “CINT”.

Conference Call Information

CI&T's senior management team will host a conference call to discuss the 3Q21 financial and operating results on December 2, 2021 at 8:00 a.m. Eastern Time / 10:00 a.m. BRT. A webcast of the conference call can be accessed at the Company’s Investor Relations website at https://investors.ciandt.com or by dialing +1 412 717-9627 (USA) or +55 11 4090 1621 (Brazil). A replay will be available on the Company’s Investor Relations website or by dialing +1-877-344-7529 (USA) or +55 11 3193 1012 (Brazil) and informing the conference ID 9949646#.

About CI&T

CI&T is a global digital specialist, a partner in end-to-end digital transformation for 50+ Large Enterprises & Fast Growth Clients. As digital natives, we bring a 26-year track record of accelerating business impact through complete and scalable digital solutions. With a global presence in 8 countries with a nearshore delivery model, CI&T is the Employer of Choice for more than 5,500 professionals in strategy, data science, design, and engineering, unlocking top-line growth, improving customer experience and driving operational efficiency.

Basis of accounting and functional currency

CI&T maintains its books and records in Brazilian reais, the presentation currency for its unaudited consolidated financial statements and the functional currency of our operations in Brazil. CI&T prepares its unaudited condensed consolidated interim financial statements in accordance with IFRS, as issued by the IASB, and International Financial Reporting Standard No 34—Interim Financial Reporting (“IAS 34”).

Non-IFRS Financial Measures

We regularly monitor certain financial and operating metrics to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections and make strategic decisions. These non-IFRS financial measures include Adjusted Gross Profit, Adjusted Gross Profit Margin, EBITDA, EBITDA Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Profit for the period, Adjusted Net Profit Margin for the period, Net Revenue at Constant Currency and Net Revenue Increase at Constant Currency, and should be considered in addition to results prepared in accordance with IFRS, but not as substitutes for IFRS results. In addition, our calculation of these non-IFRS financial measures may be different from the calculation used by other companies, and therefore comparability may be limited. These non-IFRS financial measures are provided as additional information to enhance investors’ overall understanding of the historical and current financial performance of our operations. See "Reconciliation of Non-IFRS measures, including Dextra as of August 10, 2021" and "Reconciliation of Non-IFRS measures Pro Forma, including the Dextra acquisition as if the acquisition had occurred on January 1st, 2021" for reconciliations of our Non-IFRS measures to the nearest IFRS measure.

We monitor our net revenue at constant currency and net revenue increase at constant currency. As the impact of foreign currency exchange rates is highly volatile and difficult to predict, we believe Net Revenue at Constant Currency and Net Revenue Increase at Constant Currency allow us to better understand the underlying business trends and performance of our ongoing operations on a period-over-period basis by eliminating the effect of fluctuations in the exchange rates we use in the translation of our Net revenue in foreign currencies into Brazilian reais. We calculate Net Revenue at Constant Currency and Net Revenue Increase at Constant Currency by translating Net revenue from entities reporting in foreign currencies into Brazilian reais using the comparable foreign currency exchange rates from the prior period.

Cautionary Statement on Forward–Looking Statements

This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, which include but are not limited to: the statements under "Business outlook," including expectations relating to revenues and other financial or business metrics; statements regarding relationships with clients; and any other statements of expectation or belief. The words “believe,” “will,” “may,” “may have,” “would,” “estimate,” “continues,” “anticipates,” “intends,” “plans,” “expects,” “budget,” "scheduled,” “forecasts” and similar words are intended to identify estimates and forward looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements represent our management's beliefs and assumptions only as of the date of this press release. You should read this press release with the understanding that our actual future results may be materially different from what we expect. These statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from results expressed or implied in this press release. Such risk factors include, but are not limited to, those related to: the current and future impact of the COVID-19 pandemic on our business and industry; the effects of competition on our business; uncertainty regarding the demand for and market utilization of our services; the ability to maintain or acquire new client relationships; general business and economic conditions; our ability to successfully integrate Dextra; and our ability to successfully execute our growth strategy and strategic plans. Additional information concerning these and other risks and uncertainties are contained in the "Risk Factors" section of CI&T's registration statement on Form F-1. Additional information will be made available in our annual reports on Form 20-F, and other filings and reports that CI&T may file from time to time with the SEC. Except as required by law, CI&T assumes no obligation, and does not intend to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Reconciliation of Non-IFRS measures, including Dextra as of August 10, 2021

The following table presents a reconciliation of our Non-IFRS measures, such as adjusted gross profit, EBITDA, adjusted EBITDA and adjusted net profit for the following periods:

  Three months ended September Nine months ended September 30,
 

2021

2020

2021

2020

  (in thousands of Brazilian reais) (in thousands of Brazilian reais)
Net Revenue  

375,970

 

242,897

 

987,586

 

691,152

 

Gross Profit  

129,124

 

92,582

 

346,600

 

256,580

 

Reconciliation of Adjusted Gross Profit  
Depreciation and amortization (cost of services provided)

10,345

6,092

23,121

18,091

 
Stock Options

116

43

348

62

 
Adjusted Gross Profit  

139,584

 

98,717

 

370,069

 

274,733

 

Adjusted Gross Profit Margin  

37.1

%

40.6

%

37.5

%

39.7

%

Reconciliation of EBITDA  
Net profit (loss) for the period  

(2,208

)

39,538

 

82,129

 

98,253

 

Adjustments  
Net finance costs  

22,416

 

1,891

 

26,102

 

14,036

 

Income tax expense  

18,857

 

16,386

 

57,515

 

46,287

 

Depreciation and amortization  

14,083

 

7,559

 

30,102

 

22,452

 

EBITDA  

53,147

 

65,374

 

195,848

 

181,028

 

EBITDA Margin  

14.1

%

26.9

%

19.8

%

26.2

%

Reconciliation of Adjusted EBITDA  
Net profit for the period  

(2,208

)

39,538

 

82,129

 

98,253

 

Adjustments  
Net finance costs  

22,416

 

1,891

 

26,102

 

14,036

 

Income tax expense  

18,857

 

16,386

 

57,515

 

46,287

 

Depreciation and amortization  

14,083

 

7,559

 

30,102

 

22,452

 

Stock Options  

193

 

213

 

693

 

733

 

Consulting Expenses  

4,895

 

320

 

5,357

 

320

 

Government grants  

(4

)

(673

)

(1,418

)

(1,318

)

Impairment  

21,818

 

-

 

21,818

 

-

 

Adjusted EBITDA  

80,048

 

65,234

 

222,298

 

180,763

 

Adjusted EBITDA Margin  

21.3

%

26.9

%

22.5

%

26.2

%

Reconciliation of Adjusted Net Profit (loss)  
Net profit (loss) for the period  

(2,208

)

39,538

 

82,129

 

98,253

 

Adjustments  
Impairment  

21,818

 

-

 

21,818

 

-

 

Consulting Expenses  

4,895

 

320

 

5,357

 

320

 

Adjusted Net profit (loss) for the period  

24,504

 

39,858

 

109,304

 

98,573

 

Adjusted Net profit (loss) Margin for the period  

6.5

%

16.4

%

11.1

%

14.3

%

   
Net Revenue in Constant Currency  

380,707

 

242,832

 

-

 

-

 

In calculating Adjusted Gross Profit, we exclude cost components that are not related to the direct management of our services. For the periods herein, the adjustments applied were: (i) depreciation and amortization related to costs of services provided; and (ii) stock options compensation plan expenses.

In calculating Adjusted EBITDA, we exclude components that are not related to the direct management of our services. For the periods herein, the adjustments were: (i) consulting expenses related to corporate reorganization and secondary public offering costs, as well as mergers and acquisitions activity; (ii) government grants related to tax reimbursement in the Chinese subsidiary; (iii) stock options compensation plan expenses; and (iv) the impairment related to the discontinuation of certain investments made by Dextra on certain in progress intangible assets related to digital platforms following the closing of the Dextra acquisition. CI&T does not expect a continuing impact in its operations related to this impairment.

In calculating Adjusted Net Profit, we exclude cost components that are not related to the direct management of our services. For the periods herein, the adjustments applied were: (i) consulting expenses related to corporate reorganization and secondary public offering costs, as well as mergers and acquisitions activity; and (ii) the impairment related to the discontinuation of certain investments made by Dextra on certain in progress intangible assets related to digital platforms following the closing of the Dextra acquisition. CI&T does not expect a continuing impact in its operations related to this impairment.

We calculate Net Revenue at Constant Currency and Net Revenue growth at Constant Currency by translating Net revenue from entities reporting in foreign currencies into Brazilian reais using the comparable foreign currency exchange rates from the prior period.

Reconciliation of Non-IFRS measures Pro Forma, including the Dextra acquisition as if the acquisition had occurred on January 1, 2021.(1)
(in thousands of Brazilian Reais - R$, unaudited)

Three months ended
September 2021

 

Nine months ended
September 2021

 
   
Pro forma Net Revenue

411,106

 

 

1,160,545

 

Pro forma Cost

(267,184

)

 

(744,193

)

Pro forma Gross Profit

143,922

 

 

416,352

 

Pro forma Selling, general, and administrative

(70,078

)

 

(193,364

)

Pro forma Impairment loss on trade receivables and contract assets

(1,662

)

 

(1,938

)

Pro forma Other income (expenses) net

(25,228

)

 

(24,745

)

Pro forma Operating profit before financial income

46,954

 

 

196,305

 

Pro forma Net finance costs

(28,491

)

 

(48,691

)

Pro forma Profit before Income tax

18,463

 

 

147,614

 

Pro forma Income Tax

(16,748

)

 

(58,840

)

Pro forma Net profit (loss) for the period

1,715

 

 

88,774

 

Reconciliation of Pro forma EBITDA  
Pro forma Net profit (loss) for the period

1,715

 

 

88,774

 

Adjustments  
Net finance costs

28,491

 

 

48,691

 

Income tax expense

16,748

 

 

58,840

 

Depreciation and amortization

18,967

 

 

53,527

 

Pro forma EBITDA

65,921

 

 

249,832

 

Pro forma EBITDA Margin

16.0

%

 

21.5

%

Reconciliation of Adjusted Pro forma EBITDA  
Pro forma Net profit (loss) for the period

1,715

 

 

88,774

 

Adjustments  
Net finance costs

28,491

 

 

48,691

 

Income tax expense

16,748

 

 

58,840

 

Depreciation and amortization

18,967

 

 

53,527

 

Stock Options

193

 

 

693

 

Consulting Expenses

3,825

 

 

6,617

 

Government grants

(4

)

 

(1,418

)

Impairment

21,818

 

 

21,818

 

Adjusted Pro forma EBITDA

91,753

 

 

277,542

 

Adjusted Pro forma EBITDA Margin

22.3

%

 

23.9

%

Reconciliation of Adjusted Pro forma Net Income  
Pro forma Net profit (loss) for the period

1,715

 

 

88,774

 

Adjustments  
Consulting Expenses

3,825

 

 

6,617

 

Impairment

21,818

 

 

21,818

 

Adjusted Pro forma Net profit (loss) for the period

27,358

 

 

117,209

 

Adjusted Pro forma Net profit (loss) Margin for the period

6.7

%

 

10.1

%

Please refer to the previous page for explanations of the reconciliation items for non-IFRS measures.

(1) The Pro Forma numbers for the three months ended September 30, 2021 (3Q21) are derived from the difference of the unaudited pro forma condensed statement of profit and loss for the nine months ended September 30, 2021 and the unaudited pro forma condensed statement of profit or loss for the six months ended June 30, 2021.

CI&T Software S.A.

CI&T Inc was incorporated on June 7, 2021, to become the holding entity of CI&T Software S.A. in connection with the IPO. Prior to the IPO, CI&T Inc had not commenced operations and had nominal assets and liabilities and no material contingent liabilities or commitments. Accordingly, the financial statements presented in this release are those of CI&T Software S.A., the Company’s principal operating company and wholly-owned subsidiary.

Unaudited Condensed Consolidated Interim Financial Information

Statement of profit and loss, including Dextra as of August 10, 2021
(in thousands of Brazilian Reais - R$, unaudited)

   
 

Three months ended September 30,

 

Nine months ended September 30,

 

2021

 

2020

 

2021

 

2020

   
Net Revenue  

375,970

 

242,897

 

987,586

 

691,152

 

Costs of services provided  

(246,846

)

(150,315

)

(640,986

)

(434,572

)

Gross Profit  

129,124

 

92,582

 

346,600

 

256,580

 

   
Selling expenses  

(24,122

)

(14,769

)

(61,902

)

(39,278

)

General and administrative expenses  

(38,966

)

(20,268

)

(93,056

)

(58,300

)

Research and technological innovation expenses  

-

 

(690

)

(4

)

(2,652

)

Impairment loss on trade receivables and contract assets  

(1,662

)

361

 

(2,030

)

(5

)

Other income (expenses) net  

(25,309

)

599

 

(23,862

)

2,231

 

 

(90,059

)

(34,767

)

(180,854

)

(98,004

)

Operating profit before financial income  

39,065

 

57,815

 

165,746

 

158,576

 

   
Finance income  

17,591

 

14,045

 

43,421

 

32,851

 

Finance cost  

(40,007

)

(15,936

)

(69,523

)

(46,887

)

Net finance costs  

(22,416

)

(1,891

)

(26,102

)

(14,036

)

   
Profit before Income tax  

16,649

 

55,924

 

139,644

 

144,540

 

Income tax expense  
Current  

(28,809

)

(14,178

)

(63,367

)

(42,478

)

Deferred  

9,952

 

(2,208

)

5,852

 

(3,809

)

Net profit (loss) for the year  

(2,208

)

39,538

 

82,129

 

98,253

 

   
Income attributable to:  
Controlling shareholders  

(2,208

)

39,538

 

82,129

 

98,253

 

Non-controlling interests  

-

 

-

 

-

 

-

 

Net profit (loss) for the year  

(2,208

)

39,538

 

82,129

 

98,253

 

   
Earnings per share  
Earnings per share – basic (in R$)  

(1.25

)

22.46

 

46.65

 

55.81

 

Earnings per share – diluted (in R$)  

(1.25

)

22.46

 

46.65

 

55.14

 

CI&T Software S.A.

Unaudited Condensed consolidated statements of financial information as of September 30, 2021 and December 31, 2020
(in thousands of Brazilian Reais - R$, unaudited)

Assets

September 30, 2021

December 31, 2020

Cash and cash equivalents

113,417

162,827

Trade receivables

318,400

196,256

Contract assets

147,603

50,625

Recoverable taxes

7,933

1,016

Tax assets

2,651

2,117

Derivatives

2,842

8,837

Other assets

27,696

12,874

 
Total current assets

620,542

434,552

 
 
Recoverables taxes

3,086

3,099

Deferred tax

25,985

15,152

Judicial deposits

3,075

3,083

Other assets

2,303

2,494

 

34,449

23,828

 
Property, plant and equipment

55,720

38,771

Intangible assets

745,766

18,166

Right-of-use assets

75,138

69,765

 

876,625

126,702

 
Total non-current assets

911,073

150,530

 
 
Total assets

1,531,615

585,082

CI&T Software S.A.

Unaudited Condensed consolidated statements of financial information as of September 30, 2021 and December 31, 2020
(in thousands of Brazilian Reais - R$, unaudited)

Liabilities and equity September 30, 2021 December 31, 2020
Suppliers

25,053

15,312

Loans and borrowings

138,694

75,377

Lease liabilities

20,952

14,569

Salaries and welfare charges

214,063

141,794

Accounts payable for business combination

97,701

-

Derivatives

3,295

5,392

Tax liabilities

13,671

6,078

Other taxes payable

5,874

3,279

Dividends and interest on equity payable

4,044

30,677

Contract liability

3,014

9,987

Indemnity

-

628

Other liabilities

14,855

7,899

 
Total current liabilities

541,216

310,992

 
Loans and borrowings

643,453

13,853

Lease liabilities

62,012

60,659

Provisions

507

161

Accounts payable for business combination

35,872

-

Other liabilities

694

957

 
Total non-current liabilities

742,538

75,630

 
Equity
Share capital

59,542

68,968

Capital reserves

9,007

6,764

Profit reserves

146,170

109,308

Other comprehensive income

33,142

13,420

Total equity

247,861

198,460

 
Total equity and liabilities

1,531,615

585,082

CI&T Software S.A.

Unaudited Condensed Consolidated statement of cash flows for the nine months ended September 2021 and 2020
(in thousands of Brazilian Reais - R$, unaudited)

Cash flows from operating activities  

September 30, 2021

September 30, 2020

Net profit for the year  

82,129

 

98,253

 

Adjustments for:  
Depreciation and amortization  

30,102

 

22,452

 

Gain/loss on the sale of property, plant and equipment and intangible assets  

338

 

275

 

Interest, adjusted for inflation and exchange rate changes  

25,998

 

9,161

 

Interest on lease  

4,409

 

3,497

 

Unrealized gains on financial instruments  

3,898

 

6,006

 

Income tax expense  

57,515

 

46,287

 

Provision for (reversal of) impairment losses on trade receivables and contract assets  

2,030

 

5

 

Write-off (impairment) of intangible assets  

21,818

 

-

 

Provision for labor risks  

346

 

13

 

Exchange rate changes on indemnity  

-

 

(4,413

)

Share-based plan  

694

 

733

 

Remeasurement of Right-of-Use assets  

247

 

-

 

Others  

(195

)

(119

)

   
Reduction (Increase) in operating assets and liabilities  
Trade receivables  

(87,669

)

(30,283

)

Contract assets  

(67,530

)

(16,272

)

Other taxes recoverable  

(13,260

)

(4,548

)

Current tax assets  

(2

)

505

 

Judicial deposits  

7

 

-

 

Suppliers  

4,075

 

2,821

 

Salaries and welfare charges  

43,788

 

38,889

 

Tax liabilities  

(3,797

)

(7,940

)

Other taxes payable  

1,448

 

2,295

 

Contract liability  

(9,036

)

(15,479

)

Payment of share-based indemnity  

(628

)

(38,386

)

Other receivables and payables, net  

(6,538

)

(11,047

)

   
Cash generated from operating activities  

90,187

 

102,705

 

   
Income tax paid  

(44,468

)

(30,128

)

Interest paid on loans and borrowings  

(2,296

)

(2,243

)

Interest paid on lease  

(3,972

)

(3,496

)

   
Net cash from operating activities  

39,451

 

66,838

 

   
Cash flows from investment activities  
Acquisition of property and equipment and intangible assets  

(22,112

)

(16,422

)

Business combinations  

(650,000

)

-

 

   
Net cash (used in) investment activities  

(672,112

)

(16,422

)

   
Cash flows from financing activities  
Share-based plan contributions  

989

 

1,751

 

Dividends paid  

(71,039

)

(30,977

)

Interest on equity, paid  

(713

)

(2,679

)

Payment of lease liabilities  

(12,407

)

(12,070

)

Proceeds from loans and borrowings  

740,596

 

144,270

 

Payment of loans and borrowings  

(71,702

)

(69,242

)

   
   
Net cash from (used in) financing activities  

585,724

 

31,053

 

   
Net increase in cash and cash equivalents  

(46,937

)

81,469

 

   
Cash and cash equivalents as of January 1st  

162,827

 

79,500

 

   
Exchange variation effect on cash and cash equivalents  

(2,937

)

(7,565

)

Cash reduction due to spin-off effect  

(7,752

)

-

 

Cash increase due to business combination  

8,216

 

-

 

   
Cash and cash equivalents at the end of the period  

113,417

 

153,404

 

CI&T Software S.A.

Unaudited Pro Forma Condensed Consolidated Financial Information

Pro forma statement of profit and loss for the nine months ended September 30, 2021
(in thousands of Brazilian Reais - R$, unaudited)

CI&T Dextra Transaction Accounting
Adjustments
  CI&T Pro Forma
   
Net revenue

987,586

 

 

172,959

 

 

1,160,545

 

Costs of services provided

(640,986

)

 

(103,207

)

 

(744,193

)

Gross profit

346,600

 

 

69,752

 

-

 

 

416,352

 

   

 

   

 

Selling expenses

(61,902

)

 

(1,021

)

-

 

 

(62,923

)

General and administrative expenses

(93,056

)

 

(20,010

)

(17,370

)

 

(130,436

)

Research and technological innovation expenses

(4

)

 

-

 

-

 

 

(4

)

Impairment loss on trade receivables and contract assets

(2,030

)

 

92

 

-

 

 

(1,938

)

Other income (expenses) net

(23,862

)

 

(884

)

-

 

 

(24,746

)

Operating profit before financial income

165,746

 

 

47,929

 

(17,370

)

 

196,305

 

   

 

Finance income

43,421

 

 

224

 

-

 

 

43,645

 

Finance cost

(69,523

)

 

(1,852

)

(20,961

)

 

(92,336

)

Net finance costs

(26,102

)

 

(1,628

)

(20,961

)

 

(48,691

)

   

 

Profit before Income tax

139,644

 

 

46,301

 

(38,331

)

 

147,614

 

Income tax

(57,515

)

 

(14,358

)

13,033

 

 

(58,840

)

Net profit for the period

82,129

 

 

31,943

 

(25,298

)

 

88,774

 

 

Earnings per share    

 

Earnings per share – basic (in R$) 0.047

 

 

0.050

 

Earnings per share – diluted (in R$) 0.047

 

   

0.050

 

 


ę Business Wire 2021
All news about CI&T INC.
01/14Tech Stocks Rebound This Afternoon, Led Higher by Chipmakers
MT
01/14CI&T to Buy UK Digital Product Agency Somo Global
MT
01/14CI&T Acquires Somo to Accelerate Its Growth in EMEA
BU
01/14CI&T Inc. executed a sale and purchase agreement to acquire Somo Global Ltd for ú58.8 m..
CI
2021CI&T a Winner in Global Open Finance Challenge with Financial Passport Solution for Imm..
BU
2021Goldman Sachs Starts CI&T at Buy With $23 Price Target
MT
2021Morgan Stanley Starts CI&T at Overweight With $17 Price Target
MT
2021Citigroup Starts CI&T at Buy With $17 Price Target
MT
2021BofA Securities Starts CI&T at Buy With $15 Price Target
MT
2021JPMorgan Starts CI&T at Overweight With $17 Price Target
MT
More news
Analyst Recommendations on CI&T INC.
More recommendations
Financials
Sales 2021 1 535 M 276 M 276 M
Net income 2021 132 M 23,7 M 23,7 M
Net cash 2021 227 M 40,8 M 40,8 M
P/E ratio 2021 11,1x
Yield 2021 9,17%
Capitalization 1 649 M 1 649 M 296 M
EV / Sales 2021 0,93x
EV / Sales 2022 0,61x
Nbr of Employees 5 398
Free-Float -
Chart CI&T INC.
Duration : Period :
CI&T Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CI&T INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 12,47 BRL
Average target price 100,21 BRL
Spread / Average Target 704%
EPS Revisions
Managers and Directors
Cesar Nivaldo Gon Chief Executive Officer & Director
Stanley Rodrigues Chief Financial Officer
Bruno Guicardi Operations Director
Fernando Matt Borges Martins Director
Brenno Raiko de Souza Director
Sector and Competitors
1st jan.Capi. (M$)
CI&T INC.1.51%1 596
MICROSOFT CORPORATION-7.77%2 328 976
SEA LIMITED-21.76%98 356
ATLASSIAN CORPORATION PLC-22.00%75 166
DASSAULT SYSTÈMES SE-11.92%69 154
SYNOPSYS INC.-11.49%50 045